{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T01:16:02Z","timestamp":1778030162861,"version":"3.51.4"},"reference-count":77,"publisher":"F1000 Research Ltd","license":[{"start":{"date-parts":[[2017,3,29]],"date-time":"2017-03-29T00:00:00Z","timestamp":1490745600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000072","name":"National Institute of Dental and Craniofacial Research","doi-asserted-by":"crossref","award":["R01DE025994"],"award-info":[{"award-number":["R01DE025994"]}],"id":[{"id":"10.13039\/100000072","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"crossref","award":["R01CA140337"],"award-info":[{"award-number":["R01CA140337"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["f1000research.com"],"crossmark-restriction":false},"short-container-title":["F1000Res"],"abstract":"<ns4:p>Epstein-Barr virus (EBV) is a common human herpes virus known to infect the majority of the world population. Infection with EBV is often asymptomatic but can manifest in a range of pathologies from infectious mononucleosis to severe cancers of epithelial and lymphocytic origin. Indeed, in the past decade, EBV has been linked to nearly 10% of all gastric cancers. Furthermore, recent advances in high-throughput next-generation sequencing and the development of humanized mice, which effectively model EBV pathogenesis, have led to a wealth of knowledge pertaining to strain variation and host-pathogen interaction. This review highlights some recent advances in our understanding of EBV biology, focusing on new findings on the early events of infection, the role EBV plays in gastric cancer, new strain variation, and humanized mouse models of EBV infection.<\/ns4:p>","DOI":"10.12688\/f1000research.10591.1","type":"journal-article","created":{"date-parts":[[2017,3,29]],"date-time":"2017-03-29T10:36:11Z","timestamp":1490783771000},"page":"386","update-policy":"https:\/\/doi.org\/10.12688\/f1000research.crossmark-policy","source":"Crossref","is-referenced-by-count":54,"title":["Recent advances in understanding Epstein-Barr virus"],"prefix":"10.12688","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0966-9662","authenticated-orcid":false,"given":"Brent A.","family":"Stanfield","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2964-1907","authenticated-orcid":false,"given":"Micah A.","family":"Luftig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2560","published-online":{"date-parts":[[2017,3,29]]},"reference":[{"key":"ref-1","article-title":"Fields virology.","author":"D Knipe","year":"2013"},{"key":"ref-2","doi-asserted-by":"publisher","first-page":"702-3","DOI":"10.1016\/S0140-6736(64)91524-7","article-title":"Virus Particles In Cultured Lymphoblasts From Burkitt's Lymphoma.","volume":"1","author":"M Epstein","year":"1964","journal-title":"Lancet."},{"key":"ref-3","doi-asserted-by":"publisher","first-page":"1064-5","DOI":"10.1126\/science.157.3792.1064","article-title":"Herpes-type virus and chromosome marker in normal leukocytes after growth with irradiated Burkitt cells.","volume":"157","author":"W Henle","year":"1967","journal-title":"Science."},{"key":"ref-4","doi-asserted-by":"publisher","first-page":"857-66","DOI":"10.1002\/ijc.2910030619","article-title":"Transformation of foetal human keukocytes in vitro by filtrates of a human leukaemic cell line containing herpes-like virus.","volume":"3","author":"J Pope","year":"1968","journal-title":"Int J Cancer."},{"key":"ref-5","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1750-9378-9-38","article-title":"Global burden of deaths from Epstein-Barr virus attributable malignancies 1990\u20132010.","volume":"9","author":"G Khan","year":"2014","journal-title":"Infect Agent Cancer."},{"key":"ref-6","doi-asserted-by":"crossref","first-page":"3409-14","DOI":"10.1128\/JVI.66.6.3409-3414.1992","article-title":"Epstein-Barr virus enters B cells and epithelial cells by different routes.","volume":"66","author":"N Miller","year":"1992","journal-title":"J Virol."},{"key":"ref-7","doi-asserted-by":"crossref","first-page":"186-98","DOI":"10.1016\/0042-6822(84)90102-8","article-title":"Early events in the infection of human B lymphocytes by Epstein-Barr virus: the internalization process.","volume":"132","author":"G Nemerow","year":"1984","journal-title":"Virology."},{"key":"ref-8","doi-asserted-by":"publisher","first-page":"375-85","DOI":"10.1016\/S1097-2765(02)00465-3","article-title":"Structure of the Epstein-Barr virus gp42 protein bound to the MHC class II receptor HLA-DR1.","volume":"9","author":"M Mullen","year":"2002","journal-title":"Mol Cell."},{"key":"ref-9","doi-asserted-by":"publisher","first-page":"5559-77","DOI":"10.1128\/JVI.03099-13","article-title":"Analysis of host gene expression changes reveals distinct roles for the cytoplasmic domain of the Epstein-Barr virus receptor\/CD21 in B-cell maturation, activation, and initiation of virus infection.","volume":"88","author":"M Arredouani","year":"2014","journal-title":"J Virol."},{"key":"ref-10","doi-asserted-by":"publisher","first-page":"e1002376","DOI":"10.1371\/journal.ppat.1002376","article-title":"EBV tegument protein BNRF1 disrupts DAXX-ATRX to activate viral early gene transcription.","volume":"7","author":"K Tsai","year":"2011","journal-title":"PLoS Pathog."},{"key":"ref-11","doi-asserted-by":"publisher","first-page":"10635-40","DOI":"10.1073\/pnas.1937626100","article-title":"The ATRX syndrome protein forms a chromatin-remodeling complex with Daxx and localizes in promyelocytic leukemia nuclear bodies.","volume":"100","author":"Y Xue","year":"2003","journal-title":"Proc Natl Acad Sci U S A."},{"key":"ref-12","doi-asserted-by":"crossref","first-page":"657-65","DOI":"10.1128\/JVI.29.2.657-665.1979","article-title":"Nucleosomal structure of Epstein-Barr virus DNA in transformed cell lines.","volume":"29","author":"J Shaw","year":"1979","journal-title":"J Virol."},{"key":"ref-13","doi-asserted-by":"publisher","first-page":"E1396-404","DOI":"10.1073\/pnas.1115906109","article-title":"RNAs in Epstein-Barr virions control early steps of infection.","volume":"109","author":"S Jochum","year":"2012","journal-title":"Proc Natl Acad Sci U S A."},{"key":"ref-14","doi-asserted-by":"publisher","first-page":"E6467-E6475","DOI":"10.1073\/pnas.1605884113","article-title":"Epstein-Barr virus microRNAs reduce immune surveillance by virus-specific CD8+ T cells.","volume":"113","author":"M Albanese","year":"2016","journal-title":"Proc Natl Acad Sci U S A."},{"key":"ref-15","doi-asserted-by":"publisher","first-page":"2065-80","DOI":"10.1084\/jem.20160248","article-title":"Epstein-Barr viral miRNAs inhibit antiviral CD4+ T cell responses targeting IL-12 and peptide processing.","volume":"213","author":"T Tagawa","year":"2016","journal-title":"J Exp Med."},{"key":"ref-16","doi-asserted-by":"publisher","first-page":"850-5","DOI":"10.1073\/pnas.0911948107","article-title":"AP-1 homolog BZLF1 of Epstein-Barr virus has two essential functions dependent on the epigenetic state of the viral genome.","volume":"107","author":"M Kalla","year":"2010","journal-title":"Proc Natl Acad Sci U S A."},{"key":"ref-17","doi-asserted-by":"publisher","first-page":"1037-42","DOI":"10.1128\/JVI.01416-06","article-title":"Epstein-Barr virus BZLF1 gene, a switch from latency to lytic infection, is expressed as an immediate-early gene after primary infection of B lymphocytes.","volume":"81","author":"W Wen","year":"2007","journal-title":"J Virol."},{"key":"ref-18","doi-asserted-by":"publisher","first-page":"e7214","DOI":"10.1371\/journal.pone.0007214","article-title":"Early events associated with infection of Epstein-Barr virus infection of primary B-cells.","volume":"4","author":"S Halder","year":"2009","journal-title":"PLoS One."},{"key":"ref-19","doi-asserted-by":"publisher","first-page":"1929-38","DOI":"10.1128\/MCB.14.3.1929","article-title":"Functional and physical interaction between p53 and BZLF1: implications for Epstein-Barr virus latency.","volume":"14","author":"Q Zhang","year":"1994","journal-title":"Mol Cell Biol."},{"key":"ref-20","doi-asserted-by":"publisher","first-page":"e404","DOI":"10.1371\/journal.pbio.0030404","article-title":"Epstein-Barr virus provides a new paradigm: a requirement for the immediate inhibition of apoptosis.","volume":"3","author":"M Altmann","year":"2005","journal-title":"PLoS Biol."},{"key":"ref-21","doi-asserted-by":"publisher","first-page":"e1000341","DOI":"10.1371\/journal.ppat.1000341","article-title":"An Epstein-Barr virus anti-apoptotic protein constitutively expressed in transformed cells and implicated in burkitt lymphomagenesis: the Wp\/BHRF1 link.","volume":"5","author":"G Kelly","year":"2009","journal-title":"PLoS Pathog."},{"key":"ref-22","doi-asserted-by":"publisher","first-page":"e1001294","DOI":"10.1371\/journal.ppat.1001294","article-title":"A viral microRNA cluster strongly potentiates the transforming properties of a human herpesvirus.","volume":"7","author":"R Feederle","year":"2011","journal-title":"PLoS Pathog."},{"key":"ref-23","doi-asserted-by":"publisher","first-page":"e1001063","DOI":"10.1371\/journal.ppat.1001063","article-title":"Micro RNAs of Epstein-Barr virus promote cell cycle progression and prevent apoptosis of primary human B cells.","volume":"6","author":"E Seto","year":"2010","journal-title":"PLoS Pathog."},{"key":"ref-24","doi-asserted-by":"publisher","first-page":"9967-75","DOI":"10.1128\/JVI.02244-06","article-title":"Epstein-Barr virus BHRF1 micro- and stable RNAs during latency III and after induction of replication.","volume":"81","author":"L Xing","year":"2007","journal-title":"J Virol."},{"key":"ref-25","doi-asserted-by":"publisher","first-page":"510-22","DOI":"10.1016\/j.chom.2010.11.004","article-title":"An ATM\/Chk2-mediated DNA damage-responsive signaling pathway suppresses Epstein-Barr virus transformation of primary human B cells.","volume":"8","author":"P Nikitin","year":"2010","journal-title":"Cell Host Microbe."},{"key":"ref-26","doi-asserted-by":"publisher","first-page":"11096-106","DOI":"10.1128\/JVI.01069-12","article-title":"Analysis of Epstein-Barr virus-regulated host gene expression changes through primary B-cell outgrowth reveals delayed kinetics of latent membrane protein 1-mediated NF-\u03baB activation.","volume":"86","author":"A Price","year":"2012","journal-title":"J Virol."},{"key":"ref-27","doi-asserted-by":"publisher","first-page":"e23035","DOI":"10.4161\/onci.23035","article-title":"EBV genome carrying B lymphocytes that express the nuclear protein EBNA-2 but not LMP-1: Type IIb latency.","volume":"2","author":"E Klein","year":"2013","journal-title":"Oncoimmunology."},{"key":"ref-28","doi-asserted-by":"publisher","first-page":"e87299","DOI":"10.1371\/journal.pone.0087299","article-title":"Mitogen-induced B-cell proliferation activates Chk2-dependent G1\/S cell cycle arrest.","volume":"9","author":"P Nikitin","year":"2014","journal-title":"PLoS One."},{"key":"ref-29","doi-asserted-by":"publisher","first-page":"1434-45","DOI":"10.4049\/jimmunol.1402382","article-title":"Elevation of c-MYC disrupts HLA class II-mediated immune recognition of human B cell tumors.","volume":"194","author":"J God","year":"2015","journal-title":"J Immunol."},{"key":"ref-30","doi-asserted-by":"publisher","first-page":"4550-5","DOI":"10.1073\/pnas.072495599","article-title":"MYC overexpression imposes a nonimmunogenic phenotype on Epstein-Barr virus-infected B cells.","volume":"99","author":"M Staege","year":"2002","journal-title":"Proc Natl Acad Sci U S A."},{"key":"ref-31","doi-asserted-by":"publisher","first-page":"307-14","DOI":"10.1038\/nm830","article-title":"Epstein-Barr virus infection of polarized tongue and nasopharyngeal epithelial cells.","volume":"9","author":"S Tugizov","year":"2003","journal-title":"Nat Med."},{"key":"ref-32","first-page":"769-74","article-title":"Epstein-Barr virus-associated gastric adenocarcinoma.","volume":"140","author":"D Shibata","year":"1992","journal-title":"Am J Pathol."},{"key":"ref-33","doi-asserted-by":"publisher","first-page":"6201-20","DOI":"10.18632\/oncotarget.6641","article-title":"Mutations in PI3K\/AKT pathway genes and amplifications of PIK3CA are associated with patterns of recurrence in gastric cancers.","volume":"7","author":"W Fang","year":"2016","journal-title":"Oncotarget."},{"key":"ref-34","doi-asserted-by":"publisher","first-page":"202-9","DOI":"10.1038\/nature13480","article-title":"Comprehensive molecular characterization of gastric adenocarcinoma.","volume":"513","year":"2014","journal-title":"Nature."},{"key":"ref-35","doi-asserted-by":"publisher","first-page":"739-45","DOI":"10.1007\/s00262-006-0272-1","article-title":"Contribution of the PD-L1\/PD-1 pathway to T-cell exhaustion: an update on implications for chronic infections and tumor evasion.","volume":"56","author":"C Blank","year":"2007","journal-title":"Cancer Immunol Immunother."},{"key":"ref-36","doi-asserted-by":"publisher","first-page":"10110-4","DOI":"10.1128\/JVI.01110-15","article-title":"Latent Expression of the Epstein-Barr Virus (EBV)-Encoded Major Histocompatibility Complex Class I TAP Inhibitor, BNLF2a, in EBV-Positive Gastric Carcinomas.","volume":"89","author":"M Strong","year":"2015","journal-title":"J Virol."},{"key":"ref-37","doi-asserted-by":"publisher","first-page":"236-43","DOI":"10.1136\/gutjnl-2013-304531","article-title":"Improved survival of gastric cancer with tumour Epstein-Barr virus positivity: an international pooled analysis.","volume":"63","author":"M Camargo","year":"2014","journal-title":"Gut."},{"key":"ref-38","doi-asserted-by":"publisher","first-page":"9593-8","DOI":"10.1073\/pnas.1202910109","article-title":"Infection of Epstein-Barr virus in a gastric carcinoma cell line induces anchorage independence and global changes in gene expression.","volume":"109","author":"A Marquitz","year":"2012","journal-title":"Proc Natl Acad Sci U S A."},{"key":"ref-39","doi-asserted-by":"publisher","first-page":"257-67","DOI":"10.1016\/0092-8674(80)90173-7","article-title":"DNA of Epstein-Barr virus VIII: B95-8, the previous prototype, is an unusual deletion derivative.","volume":"22","author":"N Raab-Traub","year":"1980","journal-title":"Cell."},{"key":"ref-40","doi-asserted-by":"publisher","first-page":"9094-106","DOI":"10.1128\/JVI.00785-08","article-title":"Epstein-Barr virus BART microRNAs are produced from a large intron prior to splicing.","volume":"82","author":"R Edwards","year":"2008","journal-title":"J Virol."},{"key":"ref-41","doi-asserted-by":"publisher","first-page":"4383-93","DOI":"10.1128\/JVI.00060-16","article-title":"Highly Efficient CRISPR\/Cas9-Mediated Cloning and Functional Characterization of Gastric Cancer-Derived Epstein-Barr Virus Strains.","volume":"90","author":"T Kanda","year":"2016","journal-title":"J Virol."},{"key":"ref-42","doi-asserted-by":"publisher","first-page":"8743-53","DOI":"10.1128\/JVI.01000-14","article-title":"A single amino acid in EBNA-2 determines superior B lymphoblastoid cell line growth maintenance by Epstein-Barr virus type 1 EBNA-2.","volume":"88","author":"S Tzellos","year":"2014","journal-title":"J Virol."},{"key":"ref-43","doi-asserted-by":"publisher","first-page":"5222-37","DOI":"10.1128\/JVI.03614-14","article-title":"Genome diversity of Epstein-Barr virus from multiple tumor types and normal infection.","volume":"89","author":"A Palser","year":"2015","journal-title":"J Virol."},{"key":"ref-44","doi-asserted-by":"publisher","first-page":"458-70","DOI":"10.1016\/j.celrep.2013.09.012","article-title":"Spontaneous lytic replication and epitheliotropism define an Epstein-Barr virus strain found in carcinomas.","volume":"5","author":"M Tsai","year":"2013","journal-title":"Cell Rep."},{"key":"ref-45","doi-asserted-by":"publisher","first-page":"11507-16","DOI":"10.1128\/JVI.77.21.11507-11516.2003","article-title":"HLA-A11-restricted epitope polymorphism among Epstein-Barr virus strains in the highly HLA-A11-positive Chinese population: incidence and immunogenicity of variant epitope sequences.","volume":"77","author":"R Midgley","year":"2003","journal-title":"J Virol."},{"key":"ref-46","doi-asserted-by":"publisher","first-page":"1487-502","DOI":"10.1172\/JCI58092","article-title":"EBNA3B-deficient EBV promotes B cell lymphomagenesis in humanized mice and is found in human tumors.","volume":"122","author":"R White","year":"2012","journal-title":"J Clin Invest."},{"key":"ref-47","doi-asserted-by":"publisher","first-page":"2301-12","DOI":"10.1128\/JVI.03001-14","article-title":"Epstein-Barr virus type 2 latently infects T cells, inducing an atypical activation characterized by expression of lymphotactic cytokines.","volume":"89","author":"C Coleman","year":"2015","journal-title":"J Virol."},{"key":"ref-48","doi-asserted-by":"publisher","first-page":"280-6","DOI":"10.1182\/blood.V98.2.280","article-title":"Clinical and virologic characteristics of chronic active Epstein-Barr virus infection.","volume":"98","author":"H Kimura","year":"2001","journal-title":"Blood."},{"key":"ref-49","doi-asserted-by":"publisher","first-page":"4546-59","DOI":"10.1182\/blood-2010-05-285452","article-title":"Detection of EBV genomes in plasmablasts\/plasma cells and non-B cells in the blood of most patients with EBV lymphoproliferative disorders by using Immuno-FISH.","volume":"116","author":"S Calattini","year":"2010","journal-title":"Blood."},{"key":"ref-50","doi-asserted-by":"publisher","first-page":"673-86","DOI":"10.1182\/blood-2011-10-381921","article-title":"EBV-associated T\/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases.","volume":"119","author":"H Kimura","year":"2012","journal-title":"Blood."},{"key":"ref-51","doi-asserted-by":"publisher","first-page":"66-9","DOI":"10.1086\/653424","article-title":"Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in adults characterized by high viral genome load within circulating natural killer cells.","volume":"51","author":"C Fox","year":"2010","journal-title":"Clin Infect Dis."},{"key":"ref-52","doi-asserted-by":"publisher","first-page":"527-33","DOI":"10.1086\/367988","article-title":"Prognostic factors for chronic active Epstein-Barr virus infection.","volume":"187","author":"H Kimura","year":"2003","journal-title":"J Infect Dis."},{"key":"ref-53","doi-asserted-by":"publisher","first-page":"5835-49","DOI":"10.1182\/blood-2010-11-316745","article-title":"Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States.","volume":"117","author":"J Cohen","year":"2011","journal-title":"Blood."},{"key":"ref-54","doi-asserted-by":"publisher","first-page":"256-9","DOI":"10.1038\/335256a0","article-title":"Transfer of a functional human immune system to mice with severe combined immunodeficiency.","volume":"335","author":"D Mosier","year":"1988","journal-title":"Nature."},{"key":"ref-55","doi-asserted-by":"publisher","first-page":"153-76","DOI":"10.3390\/pathogens2010153","article-title":"Humanized mouse models of epstein-barr virus infection and associated diseases.","volume":"2","author":"S Fujiwara","year":"2013","journal-title":"Pathogens."},{"key":"ref-56","doi-asserted-by":"publisher","first-page":"e135","DOI":"10.1038\/emm.2014.88","article-title":"Modeling EBV infection and pathogenesis in new-generation humanized mice.","volume":"47","author":"S Fujiwara","year":"2015","journal-title":"Exp Mol Med."},{"key":"ref-57","doi-asserted-by":"publisher","first-page":"1565-73","DOI":"10.1182\/blood-2005-02-0516","article-title":"Development of functional human blood and immune systems in NOD\/SCID\/IL2 receptor {gamma} chainnull mice.","volume":"106","author":"F Ishikawa","year":"2005","journal-title":"Blood."},{"key":"ref-58","doi-asserted-by":"publisher","first-page":"13022-7","DOI":"10.1073\/pnas.1000475107","article-title":"Generation of functional human T-cell subsets with HLA-restricted immune responses in HLA class I expressing NOD\/SCID\/IL2r gammanull humanized mice.","volume":"107","author":"L Shultz","year":"2010","journal-title":"Proc Natl Acad Sci U S A."},{"key":"ref-59","doi-asserted-by":"publisher","first-page":"1489-98","DOI":"10.1016\/j.celrep.2013.11.041","article-title":"Human natural killer cells prevent infectious mononucleosis features by targeting lytic Epstein-Barr virus infection.","volume":"5","author":"O Chijioke","year":"2013","journal-title":"Cell Rep."},{"key":"ref-60","doi-asserted-by":"publisher","first-page":"1316-22","DOI":"10.1038\/nm1431","article-title":"Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1.","volume":"12","author":"M Melkus","year":"2006","journal-title":"Nat Med."},{"key":"ref-61","doi-asserted-by":"publisher","first-page":"673-82","DOI":"10.1086\/590502","article-title":"A new humanized mouse model of Epstein-Barr virus infection that reproduces persistent infection, lymphoproliferative disorder, and cell-mediated and humoral immune responses.","volume":"198","author":"M Yajima","year":"2008","journal-title":"J Infect Dis."},{"key":"ref-62","doi-asserted-by":"publisher","first-page":"5663-73","DOI":"10.1182\/blood-2010-09-305979","article-title":"A novel animal model of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in humanized mice.","volume":"117","author":"K Sato","year":"2011","journal-title":"Blood."},{"key":"ref-63","doi-asserted-by":"publisher","first-page":"418-26","DOI":"10.1016\/j.jbspin.2007.05.001","article-title":"Pathophysiological links between rheumatoid arthritis and the Epstein-Barr virus: an update.","volume":"74","author":"E Toussirot","year":"2007","journal-title":"Joint Bone Spine."},{"key":"ref-64","doi-asserted-by":"publisher","first-page":"385-90","DOI":"10.1089\/vim.2015.0035","article-title":"Increased Epstein-Barr Virus DNA Load and Antibodies Against EBNA1 and EA in Sardinian Patients with Rheumatoid Arthritis.","volume":"28","author":"G Erre","year":"2015","journal-title":"Viral Immunol."},{"key":"ref-65","doi-asserted-by":"publisher","first-page":"2181-6","DOI":"10.19082\/2181","article-title":"Detection of Epstein-Barr virus in synovial fluid of rheumatoid arthritis patients.","volume":"8","author":"M Mahabadi","year":"2016","journal-title":"Electron Physician."},{"key":"ref-66","doi-asserted-by":"publisher","first-page":"e26630","DOI":"10.1371\/journal.pone.0026630","article-title":"Epstein-Barr virus induces erosive arthritis in humanized mice.","volume":"6","author":"Y Kuwana","year":"2011","journal-title":"PLoS One."},{"key":"ref-67","doi-asserted-by":"publisher","first-page":"e1005642","DOI":"10.1371\/journal.ppat.1005642","article-title":"PD-1\/CTLA-4 Blockade Inhibits Epstein-Barr Virus-Induced Lymphoma Growth in a Cord Blood Humanized-Mouse Model.","volume":"12","author":"S Ma","year":"2016","journal-title":"PLoS Pathog."},{"key":"ref-68","doi-asserted-by":"publisher","first-page":"3772-82","DOI":"10.1172\/JCI86923","article-title":"Cognate HLA absence in trans diminishes human NK cell education.","volume":"126","author":"V Landtwing","year":"2016","journal-title":"J Clin Invest."},{"key":"ref-69","doi-asserted-by":"publisher","first-page":"e1005344","DOI":"10.1371\/journal.ppat.1005344","article-title":"The Epstein-Barr Virus BART miRNA Cluster of the M81 Strain Modulates Multiple Functions in Primary B Cells.","volume":"11","author":"X Lin","year":"2015","journal-title":"PLoS Pathog."},{"key":"ref-70","doi-asserted-by":"publisher","first-page":"e01574-15","DOI":"10.1128\/mBio.01574-15","article-title":"Knockout of Epstein-Barr virus BPLF1 retards B-cell transformation and lymphoma formation in humanized mice.","volume":"6","author":"C Whitehurst","year":"2015","journal-title":"mBio."},{"key":"ref-71","doi-asserted-by":"publisher","first-page":"13081-6","DOI":"10.1073\/pnas.1407075112","article-title":"Effects of lymphocyte profile on development of EBV-induced lymphoma subtypes in humanized mice.","volume":"112","author":"E Lee","year":"2015","journal-title":"Proc Natl Acad Sci U S A."},{"key":"ref-72","doi-asserted-by":"publisher","first-page":"11711-4","DOI":"10.1128\/JVI.01873-15","article-title":"Epstein-Barr Viruses (EBVs) Deficient in EBV-Encoded RNAs Have Higher Levels of Latent Membrane Protein 2 RNA Expression in Lymphoblastoid Cell Lines and Efficiently Establish Persistent Infections in Humanized Mice.","volume":"89","author":"G Gregorovic","year":"2015","journal-title":"J Virol."},{"key":"ref-73","doi-asserted-by":"publisher","first-page":"803-7","DOI":"10.1093\/infdis\/jiv114","article-title":"Role of the 2B4 Receptor in CD8+ T-Cell-Dependent Immune Control of Epstein-Barr Virus Infection in Mice With Reconstituted Human Immune System Components.","volume":"212","author":"O Chijioke","year":"2015","journal-title":"J Infect Dis."},{"key":"ref-74","doi-asserted-by":"publisher","first-page":"304-15","DOI":"10.1172\/JCI76357","article-title":"LMP1-deficient Epstein-Barr virus mutant requires T cells for lymphomagenesis.","volume":"125","author":"S Ma","year":"2015","journal-title":"J Clin Invest."},{"key":"ref-75","doi-asserted-by":"publisher","first-page":"e1004333","DOI":"10.1371\/journal.ppat.1004333","article-title":"Adoptive transfer of EBV specific CD8+ T cell clones can transiently control EBV infection in humanized mice.","volume":"10","author":"O Antsiferova","year":"2014","journal-title":"PLoS Pathog."},{"key":"ref-76","doi-asserted-by":"publisher","first-page":"565-76","DOI":"10.1016\/j.ccr.2014.07.026","article-title":"Targeted activation of human V\u03b39V\u03b42-T cells controls epstein-barr virus-induced B cell lymphoproliferative disease.","volume":"26","author":"Z Xiang","year":"2014","journal-title":"Cancer Cell."},{"key":"ref-77","doi-asserted-by":"publisher","first-page":"3235-45","DOI":"10.1128\/JVI.02885-13","article-title":"T cells modulate Epstein-Barr virus latency phenotypes during infection of humanized mice.","volume":"88","author":"F Heuts","year":"2014","journal-title":"J Virol."}],"container-title":["F1000Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/f1000research.com\/articles\/6-386\/v1\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/f1000research.com\/articles\/6-386\/v1\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/f1000research.com\/articles\/6-386\/v1\/iparadigms","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,4]],"date-time":"2020-10-04T15:45:30Z","timestamp":1601826330000},"score":1,"resource":{"primary":{"URL":"https:\/\/f1000research.com\/articles\/6-386\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,29]]},"references-count":77,"URL":"https:\/\/doi.org\/10.12688\/f1000research.10591.1","relation":{"has-review":[{"id-type":"doi","id":"10.5256\/f1000research.11413.r21213","asserted-by":"subject"},{"id-type":"doi","id":"10.5256\/f1000research.11413.r21211","asserted-by":"subject"},{"id-type":"doi","id":"10.5256\/f1000research.11413.r21215","asserted-by":"subject"},{"id-type":"doi","id":"10.5256\/f1000research.11413.r21212","asserted-by":"subject"}]},"ISSN":["2046-1402"],"issn-type":[{"value":"2046-1402","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,29]]},"assertion":[{"value":"Indexed","URL":"https:\/\/f1000research.com\/articles\/6-386\/v1#article-reports","order":0,"name":"referee-status","label":"Referee status","group":{"name":"current-referee-status","label":"Current Referee Status"}},{"value":"10.5256\/f1000research.11413.r21212, Christian M\u00fcnz, Department of Viral Immunology, Institute of Experimental Immunology, University of Z\u00fcrich, Zurich, Switzerland, 29 Mar 2017, version 1, indexed","URL":"https:\/\/f1000research.com\/articles\/6-386\/v1#referee-response-21212","order":0,"name":"referee-response-21212","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"10.5256\/f1000research.11413.r21211, Alan K Chiang, Department of Paediatrics and Adolescent Medicine, The University of Hong Kong, Hong Kong, Hong Kong, 29 Mar 2017, version 1, indexed","URL":"https:\/\/f1000research.com\/articles\/6-386\/v1#referee-response-21211","order":1,"name":"referee-response-21211","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"10.5256\/f1000research.11413.r21215, Richard M. Longnecker, Northwestern University, Chicago, Chicago, IL, USA, 29 Mar 2017, version 1, indexed","URL":"https:\/\/f1000research.com\/articles\/6-386\/v1#referee-response-21215","order":2,"name":"referee-response-21215","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"10.5256\/f1000research.11413.r21213, Bo Zhao, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, USA, 29 Mar 2017, version 1, indexed","URL":"https:\/\/f1000research.com\/articles\/6-386\/v1#referee-response-21213","order":3,"name":"referee-response-21213","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"This work received funding support from the National Cancer Institute (grant R01CA140337) and the National Institute of Dental and Craniofacial Research (grant R01DE025994). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","order":4,"name":"grant-information","label":"Grant Information"},{"value":"This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.","order":0,"name":"copyright-info","label":"Copyright"}]}}